A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/2006
12/07/2006	WO2006128951A1 Compositions for targeting amine oxidases in vivo
12/07/2006	WO2006128742A2 Treatment and pre-treatment device, and manufacturing method therefor, involving nitric oxide
12/07/2006	WO2006128639A2 Process for the preparation and isolation of phosphatides
12/07/2006	WO2006128468A1 A method of manufacturing a nicotine delivery product
12/07/2006	WO2006128460A2 Pegylated g-csf polypeptides and methods of producing same
12/07/2006	WO2006128272A1 Thin foam coating comprising discrete, closed-cell capsules
12/07/2006	WO2006128266A2 Pharmaceutical compositions of the peptide angiotensin-(1 -7) [ang-(i -7)] and its analogues, agonists and antagonists, for use in controlling the functions of the reproductive system
12/07/2006	WO2006128253A1 Delivery systems
12/07/2006	WO2006110809A3 Nanoparticulate lipase inhibitor formulations
12/07/2006	WO2006103494A3 Antiviral bifunctional molecules, methods of construction and methods of treating virus-induced cancer therewith
12/07/2006	WO2006102337A3 L-arginine and zinc supplementation for repair of intestinal epithelial cell injury
12/07/2006	WO2006101839A3 Enhanced bimatoprost ophthalmic solution
12/07/2006	WO2005115360A3 Formulations of anti-pain agents and methods of using the same
12/07/2006	WO2005112919A8 Self-immolative linkers and drug conjugates
12/07/2006	WO2005048822A3 Antibodies and/or conjugates thereof which bind to the amino terminal fragment of urokinase, compositions and uses thereof
12/07/2006	US20060276676 Non-symmetrical gelling agent
12/07/2006	US20060276635 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
12/07/2006	US20060276634 PEG-conjugated erythropoietin
12/07/2006	US20060276633 Method for the mass production of immunoglobulin constant region
12/07/2006	US20060276629 Purification and characterization of soluble human HLA proteins
12/07/2006	US20060276628 Pharmaceutical Formulations and Ligands for Use Therein; Mimetics for UEA-1
12/07/2006	US20060276586 Peg-physiologically active polypeptide homodimer complex having prolonged in vivo half-life and process for the preparation thereof
12/07/2006	US20060276413 New effector conjugates, methods for their preparation and their pharmaceutical use
12/07/2006	US20060276379 Binding peptides specific for the extracellular domain of ErbB2 and uses therefor
12/07/2006	US20060276339 Methods and compositions for increasing the efficacy of biologically-active ingredients
12/07/2006	US20060275903 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
12/07/2006	US20060275868 Fusion proteins comprising tumor necrosis factor receptor
12/07/2006	US20060275791 Biological control of nanoparticle nucleation, shape and crystal phase
12/07/2006	US20060275775 Intramolecularly-quenched near infrared fluorescent probes
12/07/2006	US20060275507 Composition for preventive treatment of cold sores
12/07/2006	US20060275376 Microcapsules with modified release of active principles with low solubility for oral delivery
12/07/2006	US20060275357 Organic compounds
12/07/2006	US20060275353 Stable topical drug delivery compositions
12/07/2006	US20060275346 Liquid seasoning
12/07/2006	US20060275345 Collagen hydrolysate
12/07/2006	US20060275344 Flavoring of drug-containing chewing gums
12/07/2006	US20060275343 The applicator assembly includes a sleeve that encases a swab having a portion that contacts a gelled composition; sleeve is manually severed to expose the applicator and the composition; gelled matrix containing, glycerin, NaCl, hydroxyethyl cellulose, zinc gluconate, benzalkonium chloride, and NaOH
12/07/2006	US20060275328 Instrument for inducing cytokine and method of inducing cytokine
12/07/2006	US20060275327 In vivo modulation of neuronal transport
12/07/2006	US20060275266 Tripeptide of FcyRIIA
12/07/2006	US20060275257 G-CSF Conjugates
12/07/2006	US20060275254 covalently linked to a drug that is a physiologically active polypeptide through a non-peptide linker; nonimmunogenic; extended serum half-life of a drug while maintaining the in vivo activity
12/07/2006	US20060275252 Moiety is positioned between a water-soluble polymer and a reactive group; water soluble polymer such as polyethylene glycol containing a urethane linkage moiety for example, and a reactive group for conjugating with biodrugs
12/07/2006	US20060275251 Polymer complexes of glucuronoglucanes
12/07/2006	US20060275250 Reactive polymers and copolymers, method of their preparation and their use
12/07/2006	US20060275219 Radial spherical crystallization product, process for producing the same, and dry powder preparation containing the crystallization product
12/07/2006	US20060275213 Tumor targeting agents and uses thereof
12/07/2006	DE60118395T2 Pharmazeutische zusammensetzungen mit verzögerter freisetzung für die parenterale applikation von hydrophilen wirkstoffen Pharmaceutical compositions of active ingredients with controlled release for the parenteral administration of hydrophilic
12/07/2006	DE102005025156A1 Polares Unterstützungs- und Breitbandresonatorpräparat Polar support and Breitbandresonatorpräparat
12/07/2006	CA2611144A1 Compositions comprising a lipid and copolymer of styrene and maleic acid
12/07/2006	CA2610692A1 Ep2 agonists which may have an ep3 agonistic effect for regeneration and/or protection of nerves
12/07/2006	CA2610575A1 Process for the preparation and isolation of phosphatides
12/07/2006	CA2610414A1 Skin patch
12/07/2006	CA2610403A1 Nanoparticles comprising chitosan and cyclodextrin
12/07/2006	CA2609352A1 Delivery systems
12/07/2006	CA2609032A1 Method for producing a nucleic-acid-containing complex preparation
12/07/2006	CA2605615A1 Treatment and pre-treatment device, and manufacturing method therefor, involving nitric oxide
12/06/2006	EP1728864A1 Monoclonal antibodies specific for different epitopes of human gp39 and methods for their use in diagnosis and therapy
12/06/2006	EP1728791A1 Composition for solid pharmaceutical preparation of solifenacin or salt thereof
12/06/2006	EP1728550A1 Method for producing coated fine particles
12/06/2006	EP1728516A1 A method for inhibition of phospholamban activity for the treatment of cardiac disease and heart failure
12/06/2006	EP1728512A1 Controlled-leaching preparation and process for producing the same
12/06/2006	EP1728505A1 Preparation with elevated content
12/06/2006	EP1728504A1 Emulsion stabilizer
12/06/2006	EP1727865A1 Particle-stabilised emulsions
12/06/2006	EP1727566A2 Conjugated psychotropic drugs and uses thereof
12/06/2006	EP1727565A2 Lubricant for the ocular surface
12/06/2006	EP1727549A1 Intranasal benzodiazepine compositions
12/06/2006	EP1727532A2 Chemically stable compositions of 4-hydroxy tamoxifen
12/06/2006	EP1727530A2 Topical formulations for the treatment of skin conditions
12/06/2006	EP1727522A2 Cosmetic and pharmaceutical foam with solid matter
12/06/2006	EP1727436A1 Method of preparing a protein aggregate and a pharmaceutical composition
12/06/2006	EP1487462A4 Preparations for topical skin use and treatment
12/06/2006	EP1458369B1 Gel comprising at least a retinoid and benzoyl peroxide
12/06/2006	EP1408897A4 Gum resin as a carrier for topical application of pharmacologically active agents
12/06/2006	EP1315481B1 Medicament for treating intestinal diseases
12/06/2006	EP1221975B1 Polymer stabilized neuropeptides
12/06/2006	EP1212050B1 Formulations containing tetracyclines for treating or preventing mucositis
12/06/2006	EP1119360B1 Compositions for increasing intestinal absorption of fats
12/06/2006	EP1051204B1 Prostheses with associated growth factors
12/06/2006	EP0644771B2 Erythropoietin drug delivery system
12/06/2006	CN1874774A Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester
12/06/2006	CN1874759A Process for producing coated preparation having relieved unpleasantness
12/06/2006	CN1874755A A controlled-release composition for topical application and a method of delivering an active agent to a substrate
12/06/2006	CN1874740A Transdermal high and low molecular weight compounds
12/06/2006	CN1874679A Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
12/06/2006	CN1872348A Ligand of polyoxyethylene of containing target peptide toward to liver cancer
12/06/2006	CN1872343A Technique for preparing embolism agent of granule of polyvinyl alcohol
12/06/2006	CN1872342A Process for preparation of granular oral composition using oligosaccharide solution
12/06/2006	CN1872341A Application of amide dextrose as promoter for passing through skin
12/06/2006	CN1872069A Injection of compound aminophylline for animal use, and preparation method
12/06/2006	CN1872060A Drop pills of nitrendipine, and preparation method
12/06/2006	CN1872057A Soluble compound medicinal preparation of antibacterial drugs, and preparation method
12/06/2006	CN1872048A Drop pills of soybean aglycone, and preparation method
12/06/2006	CN1872038A Drop pill type eye drip fluid of chloramphenicol, and preparation method
12/06/2006	CN1872033A Enteric coated drop pills of garlicin, and preparation method
12/06/2006	CN1872032A Torasemide soft capsule, and preparation method
12/06/2006	CN1872031A Osmotic pump controlled release tablet of solid dispersion of hydroxy camptothecin and prepn. method
12/06/2006	CN1872028A Immune magnetic Nano microsphere, preparation method, and application
12/06/2006	CN1872027A Injection of vitriolic berberine for animal use, preparation and usage

1 ... 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 ... 1712